首站-论文投稿智能助手
典型文献
A cyclodextrin-based nanoformulation achieves co-delivery of ginsenoside Rg3 and quercetin for chemo-immunotherapy in colorectal cancer
文献摘要:
The immune checkpoint blockade therapy has profoundly revolutionized the field of cancer immunotherapy.However,despite great promise for a variety of cancers,the efficacy of immune check-point inhibitors is still low in colorectal cancer(CRC).This is mainly due to the immunosuppressive feature of the tumor microenvironment(TME).Emerging evidence reveals that certain chemotherapeutic drugs induce immunogenic cell death(ICD),demonstrating great potential for remodeling the immuno-suppressive TME.In this study,the potential of ginsenoside Rg3(Rg3)as an ICD inducer against CRC cells was confirmed using in vitro and in vivo experimental approaches.The ICD efficacy of Rg3 could be significantly enhanced by quercetin(QTN)that elicited reactive oxygen species(ROS).To ameliorate in vivo delivery barriers associated with chemotherapeutic drugs,a folate(FA)-targeted polyethylene gly-col(PEG)-modified amphiphilic cyclodextrin nanoparticle(NP)was developed for co-encapsulation of Rg3 and QTN.The resultant nanoformulation(CD-PEG-FA.Rg3.QTN)significantly prolonged blood cir-culation and enhanced tumor targeting in an orthotopic CRC mouse model,resulting in the conversion of immunosuppressive TME.Furthermore,the CD-PEG-FA.Rg3.QTN achieved significantly longer survival of animals in combination with Anti-PD-L1.The study provides a promising strategy for the treatment of CRC.
文献关键词:
作者姓名:
Dandan Sun;Yifang Zou;Liu Song;Shulan Han;Hao Yang;Di Chu;Yun Dai;Jie Ma;Caitriona M.O'Driscoll;Zhuo Yu;Jianfeng Guo
作者机构:
School of Pharmaceutical Sciences,Jilin University,Changchun 130021,China;Laboratory of Cancer Precision Medicine,The First Hospital of Jilin University,Changchun 130021,China;Pharmacodelivery Group,School of Pharmacy,University College Cork,Cork T12 YT20,Ireland;Department of Hepatopathy,Shuguang Hospital,Affiliated to Shanghai University of Traditional Chinese Medicine,Shanghai 201203,China
引用格式:
[1]Dandan Sun;Yifang Zou;Liu Song;Shulan Han;Hao Yang;Di Chu;Yun Dai;Jie Ma;Caitriona M.O'Driscoll;Zhuo Yu;Jianfeng Guo-.A cyclodextrin-based nanoformulation achieves co-delivery of ginsenoside Rg3 and quercetin for chemo-immunotherapy in colorectal cancer)[J].药学学报(英文版),2022(01):378-393
A类:
nanoformulation
B类:
cyclodextrin,achieves,delivery,ginsenoside,Rg3,quercetin,immunotherapy,colorectal,immune,checkpoint,blockade,has,profoundly,revolutionized,field,However,despite,great,promise,variety,cancers,efficacy,inhibitors,still,low,CRC,This,mainly,due,immunosuppressive,feature,tumor,microenvironment,TME,Emerging,evidence,reveals,that,certain,chemotherapeutic,drugs,immunogenic,death,ICD,demonstrating,potential,remodeling,In,this,study,inducer,against,cells,was,confirmed,using,vitro,vivo,experimental,approaches,could,be,significantly,enhanced,by,QTN,elicited,reactive,oxygen,species,ROS,To,ameliorate,barriers,associated,folate,FA,targeted,polyethylene,gly,PEG,modified,amphiphilic,nanoparticle,NP,developed,encapsulation,resultant,prolonged,blood,cir,culation,targeting,orthotopic,mouse,resulting,conversion,Furthermore,achieved,longer,survival,animals,combination,Anti,L1,provides,promising,strategy,treatment
AB值:
0.557706
相似文献
Alterations in DNA damage response and repair genes as potential biomarkers for immune checkpoint blockade in gastrointestinal cancer
Yujiao Wang;Xi Jiao;Shuang Li;Huan Chen;Xin Wei;Chang Liu;Jifang Gong;Xiaotian Zhang;Xicheng Wang;Zhi Peng;Changsong Qi;Zhenghang Wang;Yanni Wang;Na Zhuo;Jianling Zou;Henghui Zhang;Jian Li;Lin Shen;Zhihao Lu-Department of Gastrointestinal Oncology,Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education),Peking University Cancer Hospital&Institute,Beijing 100142,China;Department of Gastric&Colorectal Surgery,The First Hospital of Jilin University,Changchun 130021,China;Genecast Precision Medicine Technology Institute,Beijing 100192,China;Life Sciences Institute,Zhejiang University,Hangzhou 310058,China;Institute of Infectious Diseases,Beijing Ditan Hospital,Capital Medical University,Beijing 100015,China
A novel peptide-based probe 99mTc-PEG6-RD-PDP2 for the molecular imaging of tumor PD-L2 expression
Qi Luo;Yunwei Zhang;Zihua Wang;Yining Sun;Linqing Shi;Yue Yu;Jiyun Shi;Zhiyuan Hu;Fan Wang-Guangzhou Laboratory,Guangzhou 510005,China;Medical Isotopes Research Center and Department of Radiation Medicine,State Key Laboratory of Natural and Biomimetic Drugs,School of Basic Medical Sciences,Peking University,Beijing 100191,China;Fujian Provincial Key Laboratory of Brain Aging and Neurodegenerative Diseases,School of Basic Medical Sciences,Fujian Medical University,Fuzhou 350122,China;Key Laboratory of Protein and Peptide Pharmaceuticals,CAS Center for Excellence in Biomacromolecules,Institute of Biophysics,Chinese Academy of Sciences,Beijing 100101,China;CAS Key Laboratory of Standardization and Measurement for Nanotechnology,CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety,CAS Center for Excellence in Nanoscience,National Center for Nanoscience and Technology of China,Beijing 100190,China
Supramolecular engineering of cell membrane vesicles for cancer immunotherapy
Shaolong Qi;Haiyan Zhang;Xueyan Zhang;Xinyang Yu;Yajun Wang;Qian-Fang Meng;Kai Yang;Bing Bai;Rui Tian;Shoujun Zhu;Lang Rao;Feihe Huang;Guocan Yu-Key Laboratory of Bioorganic Phosphorus Chemistry&Chemical Biology,Department of Chemistry,Tsinghua University,Beijing 100084,China;State Key Laboratory of Supramolecular Structure and Materials,College of Chemistry,Jilin University,Changchun 130012,China;Institute of Biomedical Health Technology and Engineering,Shenzhen Bay Laboratory,Shenzhen 518132,China;State Key Laboratory of Chemical Engineering,Stoddart Institute of Molecular Science,Department of Chemistry,Zhejiang University,Hangzhou 310027,China;ZJU-Hangzhou Global Scientific and Technological Innovation Center,Hangzhou 311215,China;State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics,Center for Molecular Imaging and Translational Medicine School of Public Health,Xiamen University,Xiamen 361102,China
Pharmacological characterization of a novel metal-based proteasome inhibitor Na-AuPT for cancer treatment
Da-cai Xu;Li Yang;Pei-quan Zhang;Ding Yan;Qian Xue;Qing-tian Huang;Xiao-fen Li;Ya-li Hao;Dao-lin Tang;Q.Ping Dou;Xin Chen;Jin-bao Liu-Affliated Cancer Hospital&Institute of Guangzhou Medical University,Guangzhou 510095,China;Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation,School of Basic Medical Sciences,Guangzhou Medical University,Guangzhou 511436,China;The Department of Physiology,School of Basic Medical Sciences,Guizhou Medical University,Guiyang 550003,China;Department of Surgery,UT Southwestern Medical Center,Dallas,TX 75390,USA;Barbara Ann Karmanos Cancer Institute and Departments of Oncology,Pharmacology&Pathology,School of Medicine,Wayne State University,Detroit,MI 48201,USA
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。